CD38

Concept

A major driver of NAD+ decrease during aging, shown by Eduardo Chini's work. CD38 knockouts have stable NAD+ levels and live 15% longer.

Mentioned in 4 videos

Save the 4 videos on CD38 to your own pod.

Sign up free to keep building your knowledge base on CD38 as more episodes are added.

Get Started Free